Cargando…

The Global Fund in China: success beyond the numbers

Detalles Bibliográficos
Autores principales:	Minghui, Ren, Scano, Fabio, Sozi, Catherine, Schwartländer, Bernhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Health Organization. Published by Elsevier Ltd/Inc/BV.Published by Elsevier Ltd. 2015
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128703/ https://www.ncbi.nlm.nih.gov/pubmed/25617197 http://dx.doi.org/10.1016/S2214-109X(14)70366-3

Ejemplares similares

The Global Fund in China: Multidrug-resistant tuberculosis nationwide programmatic scale-up and challenges to transition to full country ownership
por: Wang, Lixia, et al.
Publicado: (2017)

WHO Southeast Asia regional flagships – building beyond global frameworks
por: Sarkar, Swarup
Publicado: (2023)

The EU's global action in support of universal health coverage in the time of the pandemic and beyond
por: Franz, Christian, et al.
Publicado: (2022)

Reducing child mortality in China: successes and challenges
por: Guo, Yan, et al.
Publicado: (2016)

Learning and confirming in publicly funded antiviral trials
por: Standing, Joseph F, et al.
Publicado: (2023)

Challenges of tracking funding for pandemic preparedness and response
por: Katz, Rebecca
Publicado: (2023)

Mental health of homeless people in China amid and beyond COVID-19
por: Su, Zhaohui, et al.
Publicado: (2022)

Realising equity in maternal health: China's successes and challenges
por: Guo, Yan, et al.
Publicado: (2019)

Southeast Asia needs a revolving fund for vaccines
por: Seraj Ahmad, Fariza Nasreen, et al.
Publicado: (2022)

Toward the effective and fair funding of CO(2) removal technologies
por: Honegger, Matthias
Publicado: (2023)

The lapse of federal COVID-19 funding: implications for health equity
por: Kobayashi, Kelsen, et al.
Publicado: (2023)

Softening the blow of the pandemic: will the International Monetary Fund and World Bank make things worse?
por: Kentikelenis, Alexander, et al.
Publicado: (2020)

Patient and public involvement in research: the need for budgeting PPI staff costs in funding applications
por: De Simoni, Anna, et al.
Publicado: (2023)

The disparity between funding for eye research vs. the high cost of sight-loss in the UK
por: Dewing, Jennifer M., et al.
Publicado: (2022)

Beyond bar charts
por: Saxon, Emma
Publicado: (2015)

Pandemic preparedness: synthetic biology and publicly funded biofoundries can rapidly accelerate response time
por: Vickers, Claudia E., et al.
Publicado: (2022)

Microbes and microbiomes in 2020 and beyond
por: Natarajan, Aravind, et al.
Publicado: (2020)

Brolucizumab—another anti-VEGF or beyond
por: Sharma, Ashish, et al.
Publicado: (2020)

Integrated pneumonia surveillance: pandemics and beyond
por: Ginsburg, Amy Sarah, et al.
Publicado: (2022)

Successful treatment of chronic myeloid leukemia with tyrosine kinase inhibitors goes beyond access to drugs
por: Conchon, Monika
Publicado: (2013)

Stakeholder controls and conflicts in research funding and publication
por: Buckley, Ralf C.
Publicado: (2022)

Lives saved by Global Fund-supported HIV/AIDS, tuberculosis and malaria programs: estimation approach and results between 2003 and end-2007
por: Komatsu, Ryuichi, et al.
Publicado: (2010)

Treatment of depression in older adults beyond fluoxetine
por: Wagner, Gabriela Arantes
Publicado: (2015)

Towards pandemic preparedness beyond COVID-19
por: Naguib, Mahmoud M, et al.
Publicado: (2020)

Participant stress in the COVID-19 era and beyond
por: Goldfarb, Elizabeth V.
Publicado: (2020)

Zoonoses and wet markets: beyond technical interventions
por: Barnett, Tony, et al.
Publicado: (2021)

Protection against COVID-19: beyond antibodies
por: Lacerda, Marcus Vinícius Guimarães, et al.
Publicado: (2022)

Challenges of globalization of cancer drug trials- recruitment in LMICs, approval in HICs
por: Gyawali, Bishal, et al.
Publicado: (2021)

India's one million Accredited Social Health Activists (ASHA) win the Global Health Leaders award at the 75th World Health Assembly: Time to move beyond rhetoric to action?
por: Asthana, Sumegha, et al.
Publicado: (2022)

Opportunities and challenges for telehealth within, and beyond, a pandemic
por: Blandford, Ann, et al.
Publicado: (2020)

Cellular adaptation to oxygen deficiency beyond the Nobel award
por: López-Barneo, José, et al.
Publicado: (2020)

Rethinking cancer clinical trials for COVID-19 and beyond
por: Doherty, Gary J., et al.
Publicado: (2020)

The defect challenge of wide-bandgap semiconductors for photovoltaics and beyond
por: Ganose, Alex M., et al.
Publicado: (2022)

ARF risk factors: Beyond a sore throat
por: Williams, Ashley N., et al.
Publicado: (2022)

Making Performance-Based Funding Work for Health
por: Low-Beer, Daniel, et al.
Publicado: (2007)

The case for SABR as the global standard for non-operable early-stage non-small cell lung cancer
por: Mutsaers, Adam, et al.
Publicado: (2022)

Circular RNAs as promising biomarkers in cancer: detection, function, and beyond
por: Li, Shengli, et al.
Publicado: (2019)

Oculoplastic video-based telemedicine consultations: Covid-19 and beyond
por: Kang, Swan, et al.
Publicado: (2020)

Prospects for lithium-ion batteries and beyond—a 2030 vision
por: Grey, Clare P., et al.
Publicado: (2020)

Public health surveillance of infectious diseases: beyond point mutations
por: Goodman, Laura B, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qgb9ahitgugmal5o05pqqkabpj